348 related articles for article (PubMed ID: 23796569)
1. Central hypothyroidism and its replacement have a significant influence on cardiovascular risk factors in adult hypopituitary patients.
Klose M; Marina D; Hartoft-Nielsen ML; Klefter O; Gavan V; Hilsted L; Rasmussen AK; Feldt-Rasmussen U
J Clin Endocrinol Metab; 2013 Sep; 98(9):3802-10. PubMed ID: 23796569
[TBL] [Abstract][Full Text] [Related]
2. Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis.
Abs R; Feldt-Rasmussen U; Mattsson AF; Monson JP; Bengtsson BA; Góth MI; Wilton P; Koltowska-Häggström M
Eur J Endocrinol; 2006 Jul; 155(1):79-90. PubMed ID: 16793953
[TBL] [Abstract][Full Text] [Related]
3. Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients.
Agha A; Walker D; Perry L; Drake WM; Chew SL; Jenkins PJ; Grossman AB; Monson JP
Clin Endocrinol (Oxf); 2007 Jan; 66(1):72-7. PubMed ID: 17201804
[TBL] [Abstract][Full Text] [Related]
4. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
Feldt-Rasmussen U; Wilton P; Jonsson P; ;
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
[TBL] [Abstract][Full Text] [Related]
5. Metabolic profile in growth hormone-deficient (GHD) adults after long-term recombinant human growth hormone (rhGH) therapy.
Claessen KM; Appelman-Dijkstra NM; Adoptie DM; Roelfsema F; Smit JW; Biermasz NR; Pereira AM
J Clin Endocrinol Metab; 2013 Jan; 98(1):352-61. PubMed ID: 23162104
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine.
Koulouri O; Auldin MA; Agarwal R; Kieffer V; Robertson C; Falconer Smith J; Levy MJ; Howlett TA
Clin Endocrinol (Oxf); 2011 Jun; 74(6):744-9. PubMed ID: 21521256
[TBL] [Abstract][Full Text] [Related]
7. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
Tanriverdi F; Unluhizarci K; Kula M; Guven M; Bayram F; Kelestimur F
Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
[TBL] [Abstract][Full Text] [Related]
8. Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status--3-year results from the HypoCCS Database.
Attanasio AF; Bates PC; Ho KK; Webb SM; Ross RJ; Strasburger CJ; Bouillon R; Crowe B; Selander K; Valle D; Lamberts SW;
J Clin Endocrinol Metab; 2002 Apr; 87(4):1600-6. PubMed ID: 11932289
[TBL] [Abstract][Full Text] [Related]
9. Effect of thyroxine replacement on serum IGF-I, IGFBP-3 and the acid-labile subunit in patients with hypothyroidism and hypopituitarism.
Schmid C; Zwimpfer C; Brändle M; Krayenbühl PA; Zapf J; Wiesli P
Clin Endocrinol (Oxf); 2006 Dec; 65(6):706-11. PubMed ID: 17121519
[TBL] [Abstract][Full Text] [Related]
10. Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy.
al-Shoumer KA; Cox KH; Hughes CL; Richmond W; Johnston DG
J Clin Endocrinol Metab; 1997 Aug; 82(8):2653-9. PubMed ID: 9253349
[TBL] [Abstract][Full Text] [Related]
11. The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients.
Filipsson H; Monson JP; Koltowska-Häggström M; Mattsson A; Johannsson G
J Clin Endocrinol Metab; 2006 Oct; 91(10):3954-61. PubMed ID: 16895963
[TBL] [Abstract][Full Text] [Related]
12. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
[TBL] [Abstract][Full Text] [Related]
13. Elevated leptin concentrations in growth hormone-deficient hypopituitary adults.
al-Shoumer KA; Anyaoku V; Richmond W; Johnston DG
Clin Endocrinol (Oxf); 1997 Aug; 47(2):153-9. PubMed ID: 9302387
[TBL] [Abstract][Full Text] [Related]
14. Serum free thyroxine concentration is associated with metabolic syndrome in euthyroid subjects.
Mehran L; Amouzegar A; Tohidi M; Moayedi M; Azizi F
Thyroid; 2014 Nov; 24(11):1566-74. PubMed ID: 25069017
[TBL] [Abstract][Full Text] [Related]
15. Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.
Florakis D; Hung V; Kaltsas G; Coyte D; Jenkins PJ; Chew SL; Grossman AB; Besser GM; Monson JP
Clin Endocrinol (Oxf); 2000 Oct; 53(4):453-9. PubMed ID: 11012570
[TBL] [Abstract][Full Text] [Related]
16. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.
Benedini S; Dalle Carbonare L; Albiger N; Scanarini M; Bilora F; Petrobelli F; Giannini S; Mantero F; Scaroni C
Horm Metab Res; 2006 Jan; 38(1):16-21. PubMed ID: 16477535
[TBL] [Abstract][Full Text] [Related]
17. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of metabolic syndrome in adult hypopituitary growth hormone (GH)-deficient patients before and after GH replacement.
Attanasio AF; Mo D; Erfurth EM; Tan M; Ho KY; Kleinberg D; Zimmermann AG; Chanson P;
J Clin Endocrinol Metab; 2010 Jan; 95(1):74-81. PubMed ID: 19897679
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy.
Monson JP; Jönsson P; Koltowska-Häggström M; Kourides I
Clin Endocrinol (Oxf); 2007 Oct; 67(4):623-8. PubMed ID: 17581260
[TBL] [Abstract][Full Text] [Related]
20. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects.
Roos A; Bakker SJ; Links TP; Gans RO; Wolffenbuttel BH
J Clin Endocrinol Metab; 2007 Feb; 92(2):491-6. PubMed ID: 17090642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]